ReviewTouchREVIEWS in endocrinology2026

Disease-modifying approach to cardiovascular-kidney-metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is.

Sanja Borozan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.